As of press time, the three major indexes of Hong Kong stocks fell, the Hang Seng index fell 0.36% to 20694.72 points, with a turnover of 47.498 billion; the state-owned enterprises index fell 1.33% to 7138.68 points, with a turnover of 21.023 billion; and the red chip index fell 0.13% to 4009.04 points, with a turnover of 1.832 billion.

Automobile shares rose collectively, Geely Motor rose 4.6%, Xiaopeng Motor rose 3.8%, Great Wall Motor, BYD shares rose 2.5%, Evergrande Motor rose 1.5%, Wuling Motor rose nearly 1%, Qingling Automobile shares, Beijing Automobile, ideal Automobile rose.

Gold stocks rose, the conflict between Russia and Ukraine continued, gold prices rose, Zhaojin Mining rose nearly 6%, Shandong gold rose 4.64%, and Chinese gold rose more than 1% internationally.

The concept of green electricity is strong. China Electric Power, Datang New Energy and Xinyi Energy have increased by more than 5%, and Xinte Energy and Fullett Glass have increased by more than 4%.

Pharmaceutical outsourcing concept stocks fell collectively, Yao Ming Bio fell 9.12%, Yao Ming Kant fell 6.54%, Kanglong Huacheng and Tiger Pharmaceuticals fell more than 6%.

Hot stocks

Huoyan Holdings rose 42.31% to HK $0.74, and the company has officially become the subject of Hong Kong Stock Connect trading since the beginning of this week. This will effectively enhance the attention and awareness of mainland investors to the company, and is expected to improve the stock liquidity of the company.

Xinyi Guang Neng rose 5.43% to HK $13.98. Societe Generale Securities commented that the company's performance is growing steadily and its capacity expansion plan is full. Maintain its "buy" rating with a target price of HK $14.17; CICC pointed out that its 2021 performance was basically in line with the bank's expectations and maintained its "outperform industry" rating with a target price of HK $19.10; Guotai Junan maintained its "buy" rating with a target price of HK $17.60.

Med Health rose 2.99% to HK $7.23. Deng Zhihui, chairman, chief executive and executive director of the company, bought a further 1 million shares in the company on March 7 after increasing his stake by 1.148 million shares from January 14 to February 22, 2022, involving a capital of about HK $7.2465 million. In addition, the company has been included in the eligible shares of the Shenzhen-Hong Kong Stock Connect with effect from March 7, 2022.